Fresenius Kabi AG

In News

Polpharma and Fresenius Kabi's Vedolizumab Biosimilar PB016 Clears FDA, EMA Review Acceptance - BioPharm International

BioPharm International - Jul 31, 2026

FDA approves Fresenius Kabi rituximab biosimilar in U.S. - Investing.com

Investing.com - Aug 04, 2026

Fresenius Kabi Introduces Dalbavancin for Injection (for single-dose regimen use only) - Business Wire

Business Wire - Nov 24, 2025

Fresenius Kabi Expands Simplist Portfolio of Prefilled Syringes - Contract Pharma

Contract Pharma - Dec 02, 2025

Fresenius Kabi introduces generic Dalvance - Drug Store News

Drug Store News - Dec 01, 2025

Fresenius Kabi Expands Operating Room Portfolio with New Simplist® Prefilled Syringes - Business Wire

Business Wire - Dec 02, 2025

‘Our Commitment Is Serious’: Fresenius Kabi’s CEO Pierluigi Antonelli On Biosimilars And Beyond - insights.citeline.com

insights.citeline.com - Mar 24, 2025

Fresenius lifts 2023 outlook for hospital drugs unit Kabi - Reuters

Reuters - May 25, 2023

Fresenius Kabi Introduces Calcitonin Salmon Injection, USP Synthetic - BioSpace

BioSpace - Feb 10, 2025

Fresenius Kabi Launches Calcitonin Salmon Injection to Treat Bone Disorders and Hypercalcemia - BioPharma APAC

BioPharma APAC - Feb 11, 2025

Fresenius Kabi releases epinephrine injection in new dosage strength - Drug Store News

Drug Store News - May 28, 2025

Civica Pairs With Fresenius Kabi To Supply Stelara Biosimilar - insights.citeline.com

insights.citeline.com - Aug 07, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment